SUNNYVALE, Calif., Nov. 9 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. , a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune mediated diseases and cancer, today announced that Dr. David Loury, Vice President, Preclinical Development will provide an overview of the company and its clinical programs at Merriman Curhan Ford’s 6th Annual Investor Summit.
There will be a live webcast of the presentation, which will be accessible through a link posted on the investor relations / events & webcasts section of the PCYC website, please go to http://ir.pharmacyclics.com/events.cfm.
CONTACT: Ramses Erdtmann, Vice President of Finance of Pharmacyclics,
Inc., +1-408-215-3325
Web site: http://www.pharmacyclics.com/
